Effects of an oral supplementation of germinated barley foodstuff on serum tumour necrosis factor-alpha, interleukin-6 and -8 in patients with ulcerative colitis

Ann Clin Biochem. 2011 May;48(Pt 3):233-7. doi: 10.1258/acb.2010.010093. Epub 2011 Mar 2.

Abstract

Background: The efficacy of germinated barley foodstuff (GBF) on tumour necrosis factor-alpha (TNF-α), interleukin-6 (IL-6) and -8 (IL-8) in patients with ulcerative colitis (UC) has not yet been examined. The aim of the present study was to determine the effect of administration of GBF on serum TNF-α, IL-6 and -8 levels in UC patients in remission.

Methods: Forty-one patients with UC were divided into two groups, namely control and GBF group. Twenty-one patients in the control group received standard treatment while 20 patients in the GBF group received 30 g of GBF daily by oral administration during two months of the study along with standard drug therapy.

Results: Levels of TNF-α, IL-6 and -8 all decreased in the GBF group compared with baseline during the two-month study, while in the control group all values rose. For IL-6 and -8 this effect was significant, P = 0.034 and 0.013, respectively.

Conclusions: The results of the present study showed that the consumption of GBF may reduce the level of serum TNF-α, IL-6 and -8 in patients with UC. This investigation was designed as a pilot study and the results may provide a basis for more future clinical trials.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Oral
  • Adult
  • Colitis, Ulcerative / blood*
  • Colitis, Ulcerative / therapy
  • Dietary Supplements*
  • Female
  • Germination*
  • Hordeum / metabolism*
  • Humans
  • Interleukin-6 / blood*
  • Interleukin-8 / blood*
  • Male
  • Prebiotics
  • Recurrence
  • Tumor Necrosis Factor-alpha / blood*

Substances

  • Interleukin-6
  • Interleukin-8
  • Prebiotics
  • Tumor Necrosis Factor-alpha